Palliative and End-of-life Care in Advanced Parkinson's Disease and Multiple Sclerosis

Overview

Journal Clin Med (Lond)

Specialty General Medicine

Date 2010 Aug 24

PMID 20726466

Citations 12

Authors

Colin W Campbell

Edward J S Jones

Jane Merrills

Affiliations

Soon will be listed here.

Citing Articles

Health care utilization at the end of life in Parkinson's disease: a population-based register study.

Leavy B, Akesson E, Lokk J, Schultz T, Strang P, Franzen E BMC Palliat Care. 2024; 23(1):251.

PMID: 39468712 PMC: 11520450. DOI: 10.1186/s12904-024-01581-6.

End of life care of hospitalized patients with Parkinson disease: a retrospective analysis and brief review.

Bhansali S, Assaedi E, Yu J, Mandava N, Sonneborn C, Hogue O Front Aging Neurosci. 2023; 15:1265156.

PMID: 37744391 PMC: 10511646. DOI: 10.3389/fnagi.2023.1265156.

"I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.

Koffman J, Penfold C, Cottrell L, Farsides B, Evans C, Burman R PLoS One. 2022; 17(5):e0265861.

PMID: 35617268 PMC: 9135191. DOI: 10.1371/journal.pone.0265861.

A realist review of advance care planning for people with multiple sclerosis and their families.

Cottrell L, Economos G, Evans C, Silber E, Burman R, Nicholas R PLoS One. 2020; 15(10):e0240815.

PMID: 33064749 PMC: 7567361. DOI: 10.1371/journal.pone.0240815.

EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis.

Solari A, Giordano A, Sastre-Garriga J, Kopke S, Rahn A, Kleiter I J Palliat Med. 2020; 23(11):1426-1443.

PMID: 32469284 PMC: 7583337. DOI: 10.1089/jpm.2020.0220.

References

Goy E, Carter J, Ganzini L . Parkinson disease at the end of life: caregiver perspectives. Neurology. 2007; 69(6):611-2. DOI: 10.1212/01.wnl.0000266665.82754.61. View

Dubois B, Burn D, Goetz C, Aarsland D, Brown R, Broe G . Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007; 22(16):2314-24. DOI: 10.1002/mds.21844. View

Thomas S, Macmahon D . Parkinson's disease, palliative care and older people: Part 1. Nurs Older People. 2004; 16(1):22-6. DOI: 10.7748/nop2004.03.16.1.22.c2290. View

Emre M, Aarsland D, Albanese A, Byrne E, Deuschl G, De Deyn P . Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med. 2004; 351(24):2509-18. DOI: 10.1056/NEJMoa041470. View

Lee M, Walker R, Hildreth T, Prentice W . A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage. 2006; 32(5):462-9. DOI: 10.1016/j.jpainsymman.2006.05.020. View

Snell K, Pennington S, Lee M, Walker R . The place of death in Parkinson's disease. Age Ageing. 2009; 38(5):617-9. DOI: 10.1093/ageing/afp123. View

Kalia L, OConnor P . Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler. 2005; 11(3):322-7. DOI: 10.1191/1352458505ms1168oa. View

Turner-Stokes L, Sykes N, Silber E . Long-term neurological conditions: management at the interface between neurology, rehabilitation and palliative care. Clin Med (Lond). 2008; 8(2):186-91. PMC: 4953006. DOI: 10.7861/clinmedicine.8-2-186. View

Bobholz J, Rao S . Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol. 2003; 16(3):283-8. DOI: 10.1097/01.wco.0000073928.19076.84. View

10.

Menza M, Dobkin R, Marin H, Mark M, Gara M, Buyske S . A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology. 2008; 72(10):886-92. PMC: 2677475. DOI: 10.1212/01.wnl.0000336340.89821.b3. View

11.

Higginson I, Hart S, Silber E, Burman R, Edmonds P . Symptom prevalence and severity in people severely affected by multiple sclerosis. J Palliat Care. 2006; 22(3):158-65. View